Timing of therapies for Down syndrome: the sooner, the better

Overview of attention for article published in Frontiers in Behavioral Neuroscience, October 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 4 news outlets

twitter: 7 X users

Citations

dimensions_citation: 100 Dimensions

Readers on

mendeley: 188 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 4 news stories from 4 outlets.

Uno studio per testare gli effetti del Prozac nelle sindrome di Down

Wired.it, 18 Jan 2016

I risultati dei test condotti nei modelli animali hanno catalizzato la nascita di un trial clinico per verificare l’efficacia…

Anti-Depressant Drug Believed to Improve Down Syndrome Set for Testing in the Womb

Latinos Health, 14 Jan 2016

04:30 AM EST NEW YORK - JANUARY 4: Two bottles of Prozac are seen on a pharmacy shelf January 4, 2005 in New York City.

News story from Big News Network on Wednesday 13 January 2016

Big News Network, 13 Jan 2016

Study to use Prozac to treat Down syndrome in utero

UPI.com, 13 Jan 2016

DALLAS, Jan. 13 (UPI) -- Several studies have shown the anti-depressant drug fluoxetine, sold as Prozac, has positive effects…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.